Genetic testing was needed to diagnose mitochondrial disorder MIDD in a woman with diabetes, weight loss and poor glycemic control. Glycated hemoglobin and pancreatic function improved after treatment with a DPP-4 inhibitor.
Put your clinical decision-making skills to the test with these interactive cases. Examine the factors crucial for incorporating CGM into a patient-centric approach to managing diabetes.
Many patients are yet to benefit from the advances and approaches now at our disposal for the management of type 2 diabetes. How can the gaps and delays be addressed?
People with type 2 diabetes who are on a total diet replacement program can achieve remission in the real-world setting, but with lower frequency than in clinical trials.
A rare case of fulminant type 1 diabetes induced by SJS/TEN, which had developed in a patient taking carbamazepine and phenytoin. Glucose monitoring should be considered for patients with SJS/TEN.
Our tailored content service will keep you up to date…
Receive newsletters curated for the busy specialist by our expert editorial team
With the growing importance of primary care in diabetes, this podcast discusses the evidence on continuous glucose monitoring (CGM) use, the role of primary healthcare, and practical tips for interpreting the ambulatory glucose profile (AGP) report.
Genetic testing was needed to diagnose mitochondrial disorder MIDD in a woman with diabetes, weight loss and poor glycemic control. Glycated hemoglobin and pancreatic function improved after treatment with a DPP-4 inhibitor.
A rare case of fulminant type 1 diabetes induced by SJS/TEN, which had developed in a patient taking carbamazepine and phenytoin. Glucose monitoring should be considered for patients with SJS/TEN.
The GLP-1 receptor agonist dulaglutide was unintentionally used by a woman with type 2 diabetes until the third trimester of an unplanned and unrecognized pregnancy, but what was the outcome?
Despite many recent advances in its management, type 1 diabetes remains a burden for those living with the condition.
Prof. Chantal Mathieu explains the progress being made with disease-modifying therapy for type 1 diabetes and how it has the potential to transform the current treatment landscape.
Testosterone is the representative androgen of males; it fulfills essential functions as a hormone, and it is crucial for energy homeostasis given its preventive action against obesity due to androgen receptors that regulate adiponectin production …
ObesityCardiometabolic Disease (DM and CV) (CJ Lavie, Section Editor)
Cardiovascular disease (CVD) remains the leading cause of mortality worldwide and plays a major role in rising healthcare costs. Based on the Global Burden of Disease study, worldwide cases of CVD have increased from 271 million in 1990 to 523 …
Open AccessObesityCardiometabolic Disease (DM and CV) (CJ Lavie, Section Editor)
Obesity is a known risk factor for cardiometabolic disease. Although body mass index (BMI) is an inexpensive and easily accessible metric to define and characterize obesity at a population level, it fails to account for differences in individual …
Diabetic foot ulcers (DFUs) are a serious complication of diabetes mellitus affecting more than 18 million of patients worldwide [ 1 ] with an expected rate of about 30% of patients experiencing at least one foot ulcer in their lifetime [ 2 ].
Refine the application of CGM technology in primary care to enhance the management of type 2 diabetes. Benefit from key updates and experiential learning using CGM devices, and practice your clinical decision-making skills.
Stay up to date with the rapidly changing CGM landscape. Learn how to implement and integrate CGM into diabetes management to improve patient care and outcomes.
Expert guidance on the multidisciplinary approach to identifying and managing chronic kidney disease in patients with type 2 diabetes, plus patient scenarios to assist your decision-making and put the latest clinical guidelines into context.
This program is not available to users in the UK and US.
Sarcopenia, defined as the loss of skeletal muscle mass and strength with aging [ 1 ], has serious physiological and clinical consequences, such as falls, fractures, cognitive impairment, hospitalization, and mortality [ 2 – 4 ]. Patients with type …
People with diabetes are at high risk of cardiovascular (CV) and kidney diseases, contributing to most of the diabetes-related morbidity and mortality [ 1 , 2 ]. Owing to the established safety and efficacy of sodium-glucose co-transporter-2 …
Type 2 diabetes is characterised by islet amyloid deposition, which is associated with beta cell loss and dysfunction [ 1 – 3 ]. Amyloid deposits contain the normal beta cell secretory product human islet amyloid polypeptide (hIAPP; also known as …
Type 2 diabetes (T2D) is one of the most prevalent chronic diseases in the elderly. The International Diabetes Federation (Sun et al. 2022 ) estimates that 537 million adults have diabetes worldwide, which may rise to 783 million in 2045 (Sun et …
Genetic testing was needed to diagnose mitochondrial disorder MIDD in a woman with diabetes, weight loss and poor glycemic control. Glycated hemoglobin and pancreatic function improved after treatment with a DPP-4 inhibitor.
Genetic testing was needed to diagnose mitochondrial disorder MIDD in a woman with diabetes, weight loss and poor glycemic control. Glycated hemoglobin and pancreatic function improved after treatment with a DPP-4 inhibitor.
Many patients are yet to benefit from the advances and approaches now at our disposal for the management of type 2 diabetes. How can the gaps and delays be addressed?
Many patients are yet to benefit from the advances and approaches now at our disposal for the management of type 2 diabetes. How can the gaps and delays be addressed?
